Search Results 161-170 of 17043 for Antifungal Resistance
... Resistant to Treatment ... Any active grade 3 or higher (per NCI CTCAE version 4.03) viral, bacterial, or fungal infection within 2 weeks of the first dose of the ...
Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death. Heather Carlson Kehren. September 23, 2020.
... antifungal voriconazole. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Staph bacteria are very adaptable. Many varieties have become resistant to one or more antibiotics. Because of this, more than one antibiotic may be needed to ...
Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death featured. Minnesota. Study finds lung transplant patients ...
The purpose of this study is to assess the safety, tolerability, and effectiveness of AMT-101 in subjects with chronic antibiotic-resistant pouchitis, and to ...
The purpose of this study is to evaluate the safety and effectiveness of idasanutlin monotherapy in participants with hydroxyurea (HU)-resistant/intolerant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.